CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the ...

Generative and agentic AI are reshaping the blueprint of how orgs operate, and HR plays a leading role in the transformation.

Corporate Counsel, in partnership with ALM Intelligence, on Monday released its 2025 General Counsel Report, an exclusive ...

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

HCA Healthcare raises 2025 profit forecast amidst insurance uncertainty while Centene anticipates a 2026 profitability boost ...

Coming off the high of an all-star break that featured Kyle Martin winning the home run derby and Aaron Altherr taking home the American Association All-Star game MVP, the Cleburne Railroaders kept ...

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

Even so, the panel agreed with the doctors that the line between government speech and private expression can get blurry.

The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...